Berkshire Hathaway HomeServices Announces First Global Franchise Alliance
Berkshire Hathaway HomeServices today announced the signing of its first global franchisee, Rubina Real Estate GmbH, an award-winning real estate brokerage serving central Berlin and neighboring regions. The brokerage will operate as Berkshire Hathaway HomeServices Rubina Real Estate starting in April.
“Rubina Real Estate is an ideal fit for our network and we’re excited that it will carry the distinction of Berkshire Hathaway HomeServices’ first franchisee abroad,” said Gino Blefari, president and CEO of the network. “The brokerage’s business acumen and dedication to service and growth mirror our own values and aspirations. As important, Rubina Real Estate is a market leader and is wonderfully positioned in Berlin’s vibrant real estate market.”
Along with serving the German capital region, Rubina Real Estate attracts buyers and investors to Berlin from China, India and the Middle East. The firm is an industry authority on the residential sector and is often used as a source of real estate insight among banks, lenders and real estate developers.
Rubina is a perennial honoree for Germany in the prestigious International Property Awards held each fall in London. In 2017, the brokerage was named Best Real Estate Agency and Best Property Consultant (Marketing) for all of Europe.
“We are proud to bring the Berkshire Hathaway HomeServices brand to Berlin, Germany and other key markets in which we serve clients,” said Carsten Heinrich, co-founder and managing director of Rubina Real Estate. “The brand carries the name of Warren Buffett’s Berkshire Hathaway Inc., one of the world’s most respected and trusted corporations. We believe the brand will be warmly embraced in our markets and will help us build our global brand bridging Europe, Asia and America. We look forward to a new era of growth as Berkshire Hathaway HomeServices Rubina Real Estate.”
Berkshire Hathaway HomeServices continues as America’s fastest-growing real estate brokerage network, with more than 45,000 agents and 1,400 offices named to the brand since its launch in September 2013. The network will provide Rubina Real Estate with a powerful tool suite focusing on lead generation and network referrals, marketing and social media support, international listing syndication, professional education, business consultation and more.
Heinrich, who with his leadership team will be formally introduced to the network March 5 during Berkshire Hathaway HomeServices’ annual Sales Convention in San Antonio, Texas, said he and his team look forward to exchanging client referrals with network brokerages and engaging with the U.S. real estate market. “Our alliance will be mutually beneficial,” he said. “The brand is poised for great success globally; our company is ready and eager to grow, as well.”
Blefari said Rubina Real Estate opens the door to additional global franchisees. “We’ve approached global network expansion very carefully and methodically,” he explained. “We will continue to name high-quality franchisees in the months ahead in Europe, Asia, North America and beyond.”
Berkshire Hathaway HomeServices began global expansion in 2016 by first building infrastructure including the launch of a powerful property search platform on its website, www.berkshirehathawayhs.com. Global shoppers of U.S. real estate may translate the site in 12 languages, and their property searches yield the most residential listings in any city serviced by a Berkshire Hathaway HomeServices franchisee. The network also initiated listing syndication programs that broadcast its U.S. franchisees’ listings to real estate websites worldwide.
About Berkshire Hathaway HomeServices Rubina Real Estate
Rubina Real Estate is a Berlin-based real estate brokerage company under the leadership of Managing Partner Carsten Heinrich. Since its founding in 2011, Rubina Real Estate GmbH has focused on acquiring international investors for the German real estate market, especially from China, India and the Arab world. Rubina Real Estate GmbH has already been awarded the European Property Awards Real Estate several times. Visit http://www.rubinarealestate.com/en/.
About Berkshire Hathaway HomeServices
Berkshire Hathaway HomeServices, based in Irvine, CA, is a real estate brokerage network built for a new era in residential real estate. The network, among the few organizations entrusted to use the world-renowned Berkshire Hathaway name, brings to the real estate market a definitive mark of trust, integrity, stability and longevity. The brand was just recognized for “Highest Overall Satisfaction for Repeat Home Sellers Among National Full Service Real Estate Firms” in J.D. Power’s 2017 Home Buyer/Seller Satisfaction Study. Visit www.berkshirehathawayhs.com.
Berkshire Hathaway HomeServices
+1 (949) 794-7980
Business Network / Berkshire Hathaway HomeServices Rubina Real Estate
+49 (0)30 814 64 60-27
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on